Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis ; volume:18 ; number:1 ; day:22 ; month:6 ; year:2023 ; pages:1-12 ; date:12.2023
Journal of orthopaedic surgery and research ; 18, Heft 1 (22.6.2023), 1-12, 12.2023
- Urheber
-
Yuan, Chuanjian
Liang, Yanchen
Zhu, Kai
Xie, Wenpeng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13018-023-03920-4
- URN
-
urn:nbn:de:101:1-2023092508272059604775
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yuan, Chuanjian
- Liang, Yanchen
- Zhu, Kai
- Xie, Wenpeng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
A reappraisal of generic bisphosphonates in osteoporosis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Glucocorticoid induced osteoporosis : 12 tables